Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-11-24-Speech-2-385"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20091124.35.2-385"2
lpv:hasSubsequent	lp_eu:2009-11-24-Speech-2-3862
lpv:speaker	lp:Andreas Mölzer2
lpv:spokenAs	substitute; AFCO (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2014-06-30)3 member; AFET (2009-07-16--2012-01-18)3 member; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 unknown; Freiheitliche Partei Österreichs (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3
lpv:translated text	"Mr President, particularly in the pharmaceuticals industry, of course, research and development are key when it comes to innovation and fighting diseases, which in turn, benefit EU citizens. What action will the Commission take against pharmaceuticals companies that attempt to curtail parallel trading in the medicines sector? Will it categorise such measures as anti-competitive?"@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph